5 new weight-loss drugs to watch in fight for next Ozempic
Lost and found: Life after Ozempic and other weight-loss drugs was just the start for these four people
Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage chronic conditions such as diabetes and heart disease and others to help them lose weight.
U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...
Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...
Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...
GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...
The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...
Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...
MedPage Today on MSN6d
ObesityWeek Roundup: Patients More Likely to Ration Weight-Loss DrugsSAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback